Isogenica Email Format

Biotechnology ResearchEngland, United Kingdom11-50 Employees

Isogenica is a biotechnology company that specializes in the rapid, customized discovery of VHH antibodies—single-domain binders designed to accelerate early biologics R&D and reduce development risk. It combines a proprietary CIS Display platform with the world's largest synthetic VHH libraries to enable markedly higher screening throughput and to yield high-affinity, high-specificity candidates with developability data for faster progression. The organization serves biotech and pharmaceutical partners looking to advance candidates toward clinic-ready therapeutics, and it operates within the Cambridge UK biotech ecosystem from its base in Little Chesterford, England. With more than 25 years of experience and a history of clinical-stage programs, Isogenica positions itself as a discovery partner for emerging biotechs and pharma leaders. In 2025, Isogenica announced a collaboration with Charles River Laboratories to integrate its discovery platforms with Charles River's drug discovery capabilities.

Get verified Isogenica emails free

Company overview Employee directory